跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Cross-linked Sodium Hyaluronate Injection
Approved
化学药品
Cross-linked Sodium Hyaluronate Injection
GENZYME CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
Jul 29, 2021
Approval ID
8Dqlh2MlXf1
Company
GENZYME CORPORATION
Type
化学药品
Approval Details
Approval Id
8Dqlh2MlXf1
Approval Number
国药准字HJ20160464
Generic Name
交联玻璃酸钠注射液
Generic Name En
Cross-linked Sodium Hyaluronate Injection
Trade Name
欣维可
Drug Type
化学药品
Dosage Form
注射剂
Strength
2ml:玻璃酸钠16mg
Reg Date
2021-07-29
Expired Date
2026-07-28
Company Name
GENZYME CORPORATION
Production Company Name
GENZYME CORPORATION
Company Detail Path
/organization/genzyme-corporation
Production Company Detail Path
/organization/genzyme-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 29, 2021
Approval ID
8Dqlh2MlXf1
Type
化学药品
Back to NMPA Approvals
欣维可 - NMPA Drug Approval Details